| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-22 |
| filingDate |
1996-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f0d492f0450dae8bd0907faca3d57e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b668ac2d47a14b193bfe7e8a988118a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_623e09629e645a84e33034da282ffd5a |
| publicationDate |
1998-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5721272-A |
| titleOfInvention |
Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides |
| abstract |
This invention provides compounds of the formula: <IMAGE> The invention further provides the use of this compound to prepare N,N'-bridged bisindolylmaleimides. Furthermore, the invention provides pharmaceutical formulations and the methods of use for inhibiting Protein Kinase C in mammals. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6359130-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02059342-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6300106-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2181999-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6127401-A |
| priorityDate |
1996-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |